Max Robotics — Global Service Robot Directory + US Certification

About

Philipp Brantner is a leading figure in urologic oncology, whose work is fundamentally reshaping how prostate cancer is diagnosed and surgically treated. His primary research focuses on the intersection of advanced imaging, robotics, and personalized surgical planning. Brantner’s landmark study on robotic-assisted MRI-US fusion biopsy (2021, 17 citations) revealed a critical limitation in current practice: up to 70% of prostate cancer lesions exhibit intralesional heterogeneity, meaning a single biopsy core can miss aggressive disease. This finding has profound implications for targeted biopsy protocols, pushing the field toward more comprehensive sampling strategies. Demonstrating his commitment to precision surgery, Brantner pioneered the use of personalized 3D-printed prostate models (2024, 5 citations) to guide secondary resection of positive surgical margins during robot-assisted radical prostatectomy. This innovative approach allows surgeons to visualize and excise residual tumor with unprecedented accuracy, directly addressing a major cause of cancer recurrence. By combining rigorous diagnostic assessment with cutting-edge intraoperative tools, Brantner is not only improving cancer detection but also refining surgical techniques to preserve patient quality of life. His work stands at the forefront of the shift toward truly individualized prostate cancer care.